Wegovy pill sales smash forecasts, sending Novo Nordisk stock 7% higher
CNBC1 min read
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC